Description

Mixtard 30HM Penfil suspension for inj. 100 IU/ml. 3 ml. cartridge №5

Ingredients

Mixtard 30HM Penfil contains a combination of insulin human and insulin human isophane in the ratio of 30:70. Other ingredients include metacresol, glycerol, zinc chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid, and water for injections.

Dosage

Mixtard 30HM Penfil should be administered subcutaneously. The dosage may vary depending on the individual’s needs and should be determined by a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully.

Indications

Mixtard 30HM Penfil is indicated for the treatment of diabetes mellitus in adults. It helps control blood sugar levels by regulating glucose metabolism. It is essential for managing both type 1 and type 2 diabetes.

Contraindications

Mixtard 30HM Penfil is contraindicated in patients with hypersensitivity to insulin or any of the excipients in the formulation. It should not be used during episodes of hypoglycemia or in cases of hyperglycemia when adjustments can be made through diet or dosage changes.

Directions

Before use, inspect the Mixtard 30HM Penfil cartridge for any signs of damage or tampering. Administer the suspension subcutaneously, rotating injection sites to prevent lipodystrophy. Follow the healthcare provider’s instructions for proper administration.

Scientific Evidence

Studies have shown that the use of Mixtard 30HM Penfil in the management of diabetes mellitus leads to improved glycemic control and reduces the risk of long-term complications associated with the disease. Research published in the Journal of Diabetes Research highlighted the efficacy of Mixtard insulin in achieving target HbA1c levels.

Additional Information

It is important to monitor blood glucose levels regularly while using Mixtard 30HM Penfil to adjust the dosage as needed. Consult a healthcare provider for any concerns regarding the administration or effects of this medication.

Pharmacologically, Mixtard 30HM Penfil acts by mimicking the natural insulin production in the body, helping cells absorb glucose for energy. The combination of regular and isophane insulin provides both immediate and long-acting effects, offering better control over blood sugar levels.

Clinical trials comparing Mixtard 30HM Penfil with other insulin formulations have shown comparable effectiveness in glycemic control and a lower risk of hypoglycemic episodes. This makes it a valuable option for individuals requiring insulin therapy for diabetes management.